Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer
Clinical trial NCT02980965 · COMPLETED
Trial details
- NCT number
- NCT02980965
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2017-02-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.